📰 Discovery Platform News
Page 4 - Discovery Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Discovery Platform. Real-time updates on events, politics, business and more.
June 13, 2023
Based on forthcoming completion of patient enrollment and duration of follow-up in Cohort 2 from the phase 2 trial in late-stage NSCLC
June 8, 2023
Nicoletta Loggia, PhD, RPh, biopharma executive with more than two decades of technical expertise in the biopharmaceutical industryNEEDHAM, Mass., June 08, 2023 -- Candel Therapeutics, Inc. , a... | June 8, 2023
May 30, 2023
Public-Private Partnership Secures $14 Million Funding for Fusion Power Industry Key Highlights First Light Fusion, the University of Oxford, the University of...
April 25, 2023
/PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets...
April 25, 2023
SAN JOSE, Calif., April 25, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is proud to announce that it has received a US Patent for its natural Ayurved based product, Artovid-20® Tablets
April 13, 2023
Expert Car and Truck Reviews 1993-2024, Used Car Specs, Crash tests, Service Bulletins, Recalls, MPG, and Other Purchase Consideration Decision Making Research and Road Tests
March 7, 2023
Biopharmaceutical research company specializing in cannabis- and plant-inspired medicines shares strategic plan for 2023 and key developments from 2022LAS VEGAS, NV / ACCESSWIRE / March 7, 2023 / Gb Sciences
February 15, 2023
SAN JOSE, Calif., Feb. 15, 2023 /PRNewswire/ -- Bioved Pharmaceuticals, Inc. is pleased to announce the launch of its scientifically validated Natural Animal Health products from the science
February 15, 2023
/PRNewswire/ -- Bioved Pharmaceuticals, Inc. is pleased to announce the launch of its scientifically validated Natural Animal Health products from the science...
January 5, 2023
/PRNewswire/ -- Integral Molecular, the industry leader in antibody discovery for membrane proteins, has published the targeting mechanism enabling...